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Abstract
Background: The diagnosis of acute appendicitis can be surprisingly difficult without computed tomography,
which carries significant radiation exposure. Circulating blood cells may carry informative changes in their RNA
expression profile that would signal internal infection or inflammation of the appendix.
Methods: Genome-wide expression profiling was applied to whole blood RNA of acute appendicitis patients versus
patients with other abdominal disorders, in order to identify biomarkers of appendicitis. From a large cohort of
emergency patients, a discovery set of patients with surgically confirmed appendicitis, or abdominal pain from
other causes, was identified. RNA from whole blood was profiled by microarrays, and RNA levels were filtered by a
combined fold-change (>2) and p value (<0.05). A separate set of patients, including patients with respiratory
infections, was used to validate a partial least squares discriminant (PLSD) prediction model.
Results: Transcript profiling identified 37 differentially expressed genes (DEG) in appendicitis versus abdominal pain
patients. The DEG list contained 3 major ontologies: infection-related, inflammation-related, and ribosomal
processing. Appendicitis patients had lower level of neutrophil defensin mRNA (DEFA1,3), but higher levels of
alkaline phosphatase (ALPL) and interleukin-8 receptor-ß (CXCR2/IL8RB), which was confirmed in a larger cohort of
60 patients using droplet digital PCR (ddPCR).
Conclusions: Patients with acute appendicitis have detectable changes in the mRNA expression levels of factors
related to neutrophil innate defense systems. The low defensin mRNA levels suggest that appendicitis patient’s
immune cells are not directly activated by pathogens, but are primed by diffusible factors in the microenvironment
of the infection. The detected biomarkers are consistent with prior evidence that biofilm-forming bacteria in the
appendix may be an important factor in appendicitis.
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Background
Abdominal pain is a major cause of hospital visits,
accounting for about 10 % of 62 million visits per year
by adults who present at an emergency department (ED)
for non-injury causes [1]. Acute appendicitis is one of
the most common causes of abdominal pain and results
in nearly 750,000 ED visits with approximately 250,000
appendectomies performed annually. Globally, a small
but significant portion of the operations are “negative
appendectomies”, resulting in the removal of a non-
inflamed appendix due to misdiagnosis [2–4], reported
as high as 17-28 % outside the United States (US) and
Western Europe [5, 6].
Prior to the widespread availability of computed tomog-
raphy (CT) scans, the accurate diagnosis of appendicitis
could be challenging, and in places where CT is still not
available, the Alvarado score of clinical characteristics is a
* Correspondence: mcc@gwu.edu
2Department of Medicine, Division of Genomic Medicine, The George
Washington University Medical Center, 2300 I Street, NW Ross 443,
Washington, DC 20037, USA
4Department of Microbiology, Immunology, and Tropical Medicine, The
George Washington University Medical Center, 2300 I Street, NW Ross 443,
Washington, DC 20037, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Chawla et al. BMC Medical Genomics  (2016) 9:40 
DOI 10.1186/s12920-016-0200-y
widely used diagnostic tool [5, 6]. Currently in the US, CT
scanning is the ‘gold standard’ for the diagnosis of appen-
dicitis, with magnetic resonance imaging (MRI) being a
reasonable alternative in pregnant women [7], and ultra-
sound sonography being an acceptable alternative for
preliminary diagnostics to avoid radiation [8]. While CT is
the most sensitive and specific diagnostic tool for appendi-
citis [9, 10], and used in almost 98 % of patients undergo-
ing appendectomy in the US [11], CT scanning carries a
significant radiation exposure, and epidemiologic data
suggest that radiation exposure can increase the risk of
developing a future malignancy [12]. This issue is of par-
ticular concern in children because they are more sensitive
to the hazards of radiation, they are among the most com-
mon patients to present to the ED with abdominal pain,
and have the highest rate of misdiagnosis [10, 13]. In an
attempt to reduce the damaging effect of CT scans, several
clinical trials are examining the diagnostic utility of lower
doses of radiation, primarily in children [14–16].
In order to understand the landscape of the immune
reaction to appendicitis, we tested the hypothesis that
microarray profiling of whole blood RNA would identify
blood biomarkers of appendicitis. Toward that goal, we
employed genome-wide profiling of RNA transcripts in
whole blood RNA of patients presenting at the ED for
abdominal pain, resulting in confirmed appendicitis
versus other abdominal abnormalities. Ultimately, there
is the potential to use blood RNA biomarkers as a pre-
screening method to utilize CT scanning more appropri-





The protocol of this observational study was approved by
the Institutional Review Board of The George Washington
University, and all subjects gave informed consent. From a
cohort of 270 patients presenting to the ED for various
reasons, a subset of 40 subjects with a principal complaint
of abdominal pain, and who met inclusion/exclusion
criteria (Additional file 1: Table S1), were identified, and
divided into a discovery set of 20 patients, and a validation
set of 20 patients for transcript profiling of whole blood
RNA by microarray.
Discovery Set For the discovery set, we employed 20
subjects who presented to the ED who were undergoing
CT scanning. In order to meet criteria, the patient
undergoing the CT scan must have had appendicitis
suspected in the differential diagnosis. Appendicitis
Patients: Patients with appendicitis were diagnosed by
CT scanning (n = 11), and had research blood samples
drawn by venipuncture after anesthetic induction, but
prior to skin incision for appendectomy. All cases of ap-
pendicitis were confirmed by surgical inspection and
histopathology, including mucosal ulceration and
neutrophil infiltration of the lamina propria and/or peri-
vascular space. Control Patients: Patients included in the
control arm (n = 9) were patients who were found not to
have appendicitis, by both CT scanning and clinical
follow-up. This included patients with reported abdom-
inal pain (ABD), later found to be caused by diverticu-
litis, colitis, or other gastrointestinal pathologies, but not
clinically associated with appendicitis. Blood was drawn
at study enrollment for these patients.
Validation Set: control patients Because appendicitis
can involve infection, 5 patients with lower respiratory tract
infections (LRI) in the ED were enrolled as an ‘infection’
control. Also, as a control for surgical factors, 5 patients
undergoing elective ventral hernia or inguinal hernia repair
(HER) were enrolled, and they were compared with 9 new
patients with surgically confirmed appendicitis (APP). In all
surgical patients, including appendicitis and hernia repairs,
research blood samples were drawn by venipuncture after
anesthetic induction, and prior to skin incision. Two pa-
tients, (1 HER, 1 APP) were excluded due to technical com-
plications in RNA purification or microarray analysis.
Clinical diagnoses on all patients analyzed are available in
Additional file 2: Table S2.
Blood samples
Blood was drawn in 3.2 % sodium citrate tubes for fro-
zen plasma samples, in Tempus Blood RNA tubes (ABI)
for genome-wide RNA profiling, and in BD Vacutainer
K2 tubes for complete blood counts with differentials.
RNA purification for transcript profiling
Tempus Blood RNA preservation tubes were stored at
−80 ° C and then thawed at 37 ° C prior to processing
according to manufacturer’s methods. Total RNA was
purified from whole blood using Tempus Blood RNA kit
(ABI), followed by an aggressive DNAse treatment.
Briefly, the preserved whole blood was pelleted at 3000 x
g for 30 min in a 4 °C refrigerated centrifuge, redissolved
in lysis buffer, and nucleic acids were bound to a
column. After washing, nucleic acids were eluted with
nuclease-free water and quantified with a NanoDrop
ND-1000 spectrophotometer. DNA was eliminated by
aggressive DNAse treatment (TurboDNAse, Ambion) at
2 U/10 μg nucleic acids, followed by affinity removal of
the DNAse. The remaining RNA was quantified by 260/
280 ratio by NanoDrop, and RNA integrity was evalu-
ated by capillary electrophoresis on a Bioanalyzer 2100
(Agilent). RIN scores >7 were considered acceptable for
further sample processing and did not differ between
groups.
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Microarray expression profiling and analysis
Purified RNA (100 ng) was labeled with the Illumina
cRNA synthesis kit and hybridized to Illumina Human
HT-12v4 Expression BeadChip arrays containing 45,966
probes derived from the NCBI RefSeq release 38. The
arrays were washed and then fluorescence was quanti-
tated on an Illumina HiScan.
The fluorescence levels per bead were converted to
transcript levels using Illumina GeneStudio, which aver-
aged ~30 beads per transcript to produce a mean expres-
sion level for each of the 46 K transcripts. Raw BeadChip
fluorescence values were imported into GeneSpring
GX12.5 with normalization to the 75−percentile of expres-
sion, but without baseline transformation. The main effect
of identifying differentially expressed genes (DEG) with re-
spect to appendicitis versus controls was achieved by a
combined filter for a p value <0.05 on t test without cor-
rection for multiple testing, and 2) fold change > 2.0. The
DEG list was further analyzed for gene ontologies using
DAVID [17]. Using the DEG list, a partial least squares
discriminant (PLSD) prediction model was built in Gene-
Spring and internally validated with a Leave One Out
Cross Validation (LOOCV) algorithm. The PLSD model
was externally tested by applying the algorithm to a separ-
ate validation set of microarray samples not involved in
building the model.
Validation by droplet digital PCR (ddPCR)
In addition to the patient samples used for the discovery
and validation microarray studies, an additional 29 patients
(12 APP, 17 ABD) were drawn from the same cohort, to
compose a cohort for ddPCR validation (30 APP, 25 ABD,
5 HER). RNA was purified from Tempus-preserved whole
blood as described above and DNAse-treated prior to
quantitative PCR using a ddPCR system (BioRad QX200).
Total RNA was reverse transcribed with an RNAseH+ re-
verse transcriptase (iScript, BioRad) using random hexamer
primers. The cDNA was purified and amplified with
transcript-specific primers for ALPL, IL8RB, DEFA1, and
ACTB (Additional file 3: Table S3). ddPCR uses clear oil to
create thousands of individual nanoliter-sized droplets con-
taining cDNA and PCR reagents with a fluorescent detec-
tion dye EVAgreen. The number of positive droplets is
proportional to the abundance of the cDNA target of inter-
est, and can be calculated in absolute quantity from a
Poisson distribution. To account for variations between
RNA preparations, the quantity of target transcripts ALPL,
IL8RB, and DEFA1 was expressed as a % of the ACTB
levels in the sample.
Statistical analysis
Summary statistics are reported as mean and standard
error of measurement (SEM). Comparisons between
groups are made by an unpaired Student’s t test with
correction for multiple testing using the method of
Benjamini and Hochberg, unless otherwise specified.
Correlations between multiple measures of samples were
computed as the Pearson r statistic.
Results
Clinical parameters
As shown in Table 1, the clinical parameters between
patients presenting with appendicitis versus other ab-
dominal indications in the discovery set were generally
similar. Age, gender, and body mass index (BMI) were
comparable, although the appendicitis patients in the
discovery set were all Caucasian. Notably, white blood
cell (WBC) counts were comparable, but appendicitis
Table 1 Demographic, clinical, and laboratory findings of patients
in the discovery cohort
Unit APP (11) ABD (9)
Gender %M 54.55 55.56
Age Mean Years 40.73 45.89
SD 15.45 15.54
BMI Mean BMI 24.51 26.44
SD 4.92 4.48
Race %C 100.00 55.56
%AA 0.00 44.44
Smoker % 18.18 11.11
Duration of Symptom Mean Hours 29.45 32.75
SD 18.68 30.65
Temperature Mean Celsius 36.97 36.80
SD 0.47 0.38
WBC Mean K/ul 13.06 13.23
SD 6.44 30.65
Elevated Neutrophils >75 % % 55.00 37.50
Neutrophils Mean %WBC 77.18 70.00
SD 8.76 10.14
Creatinine Mean 0.78 1.54*
SD 0.13 1.06
pH <7.35 % 0.00 11.11
Na < 130 % 0.00 0.00
HCT < 30 % 0.00 11.11
Glu > 250 % 0 0
Total RNA conc. Mean ng/ul 102.36 66.48
Immunosupressed SD 72.49 34.06
Folds amp. Mean fold 67.96 64.13
Antibiotic use SD 60.48 35.81
Defensin Score Mean RNA level 1.26 2.62*
SD 0.92 1.46
*indicates p < 0.05 (uncorrected t-test probability)
% indicates the percent of patients exhibiting that trait, unless
otherwise indicated
Chawla et al. BMC Medical Genomics  (2016) 9:40 Page 3 of 11
patients had a slightly higher percentage of neutrophils,
which was not statistically significant (77.18 % vs 70 %,
NS). Appendicitis patients had significantly lower blood
creatinine level (0.78 vs 1.54 mg/dL, p = 0.03 uncor-
rected). The two groups did not yield significantly differ-
ent RNA quantities from blood, and the efficiency of
RNA amplification for microarray labeling was similar.
Identification of RNA biomarkers for appendicitis in whole
blood
A scatterplot of the expression patterns in the 2 groups
(Fig. 1) suggested that there was excellent linearity of
quantitation over roughly 7 log2 orders of magnitude,
with globins being the most highly and identically
expressed transcripts between groups. By comparing the
expression profiles of the two groups, and filtering for
both a t-test probability <0.05 and a fold-change of >2.0,
37 transcripts were identified as significantly differen-
tially expressed (Table 2). Hierarchical clustering of the
37 DEG was conducted to observe the pattern of covari-
ance of the transcripts in these patients. A heatmap of
the expression of these 37 transcripts across all 20 pa-
tients in the discovery set is shown in Fig. 2.
Functional analysis of DEG transcripts
Of the well annotated transcripts, several had prior pub-
lished relationships to infection, immunity, or inflammation,
or stress/injury: notably, alkaline phosphatase liver/bone/
kidney isoform (ALPL), carbonic anhydrase IV (CA4), che-
mokine (C-X-C motif) receptor 1 (CXCR1/IL-8 receptor α),
defensin α1 (DEFA1), defensin α3 (DEFA3), IgG Fc receptor
IIb (FCGR3B/CD16B), interleukin 8 receptor ß (CXCR2/
IL8RB), ninjurin 1, (NINJ1), prokinectin 2 (PROK2), and
superoxide dismutase 2 (SOD2). In addition to their logical
connection to appendicitis, which often has an infectious
etiology, certain aspects of this expression pattern increase
the confidence that some of these changes are non-random:
1) multiple probe sets identifying the same transcript
(DEFA1), 2) ‘hits’ on highly related transcripts, such as
DEFA1 and DEFA3, as well as CXCR1 (IL8 receptor α) and
CXCR2 (IL8 receptor ß).
Defensins
To understand the defensin pathway, the 5 α-defensin
transcripts in the DEG list, which are all variant tran-
scripts from the DEFA locus at 8p21.3, were averaged to
create a ‘defensin score’, and then compared between
groups (Table 1). Using a threshold determined by the
mean of all 20 patients (1.87), 6 of 9 (67 %) patients with
other abdominal disorders showed elevated defensins,
while only 1 of 11 (9 %) of appendicitis patients had ele-
vated defensin mRNA (see defensin cluster in Fig. 2).
Surprisingly, the defensin score was essentially uncorre-
lated with white blood cell count (WBC) (r = 0.07) and
neutrophil % (r = 0.15).
Other immune/inflammatory pathways
Interestingly, 3 of the 37 DEG (LILRA3, CXCR1/IL8RA,
FCGR3A), which were higher in appendicitis patients
compared to abdominal pain patients, are near or exact
matches to transcripts discovered previously as down-
regulated by exposure of isolated human neutrophils to E.
Coli [18]. However, across the 20 patients, they were not
inversely correlated with defensin expression (LILRA =
0.02, CXCR1 = −0.02, FCGR3A= −0.33), suggesting they
are regulated independently of infectious markers.
Ribosomal transcripts
While it is widely assumed that ribosomal RNAs (rRNA),
such as 18S and 28S non-coding RNAs are ‘invariant’, or
‘housekeeping’ transcripts, there is considerable evidence
that they are carefully regulated in cases such as granulo-
cyte activation [19], and differ significantly in prostate
cancer [20], and in hepatitis C infected livers [21]. In fact,
early studies with PHA-activated human lymphocytes
demonstrated as much as 8-fold increases in rRNA levels
within 20 h [22, 23]. Furthermore, if the observed changes
were due to some type of loading or processing anomaly,
then we would expect all of the ribosomal RNAs to be af-
fected in the same direction, when in fact, 18S and 28S
noncoding transcripts were increased in appendicitis, but
most of the transcripts coding for ribosomal proteins were
decreased, suggesting that this is a regulated process.
Fig. 1 Scatterplot of transcript levels in patients with appendicitis.
Whole blood RNA from patients with acute, surgically confirmed
appendicitis (n = 11) or abdominal pain (n = 9) was profiled for the
expression level of 45,966 transcripts on Illumina BeadChip Arrays
(12v4). The expression level of each transcript was averaged within
groups and plotted on a log2 scale to reveal transcripts which differ
between more than 2-fold between groups (outside parallel lines)
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Minimally annotated transcripts
Of the 37 DEG, 11 transcripts were minimally annotated,
i.e. ‘predicted transcript’, but further manual annotation
using NCBI Gene revealed high likelihood assignments.
Remarkably, 8 of the 11 transcripts were identified as ribo-
somal protein pseudogenes, which is quite unlikely to
have occurred by chance. Two transcripts have been dis-
continued, and the eleventh was identified as CYSTM1
(C5ORF32), which is a cysteine-rich transmembrane
module-containing protein that 2-hybrid screens identi-
fied as an inhibitor of the glucagon-like peptide 1 receptor
(GLP-1R) [24].
Table 2 Differentially expressed genes (DEG) sorted by functional grouping
Probe Fold Expression Level
ID p Val Change ABDOM APPDX Definition Symbol
Chemokines and immune-related
3440669 0.008 2.02 ⬆ 1.85 2.86 Chemokine C-X-C receptor 1 CXCR1
2900327 0.003 2.59 ⬆ 2.80 4.17 Interleukin 8 receptor, ß (CXCR2) CXCR2
1450139 0.004 3.07 ⬆ 3.17 4.79 Fc frag of IgG receptor IIIb (CD16b) FCGR3B
6370315 0.017 3.16 ⬆ −0.11 1.55 MHC class II, DR beta 5 HLA-DRB5
6110037 0.007 2.36 ⬆ 2.38 3.62 Leukocyte IgG-like receptor A3 LILRA3
Defensins
4540239 0.019 2.80 ⬇ 3.39 1.91 Defensin, alpha 1 DEFA1
870477 0.024 2.29 ⬇ 2.60 1.40 Defensin, alpha 1B (3 probesets) DEFA1B
2970747 0.017 2.69 ⬇ 2.58 1.15 Defensin, alpha 3, neutrophil-spec. DEFA3
Translation and protein synthesis
3180609 0.002 2.69 ⬆ 1.04 2.47 18S ribosomal RNA, non-coding 18S rRNA
6280504 0.005 2.05 ⬆ 1.20 2.23 28S ribosomal RNA, non-coding 28S rRNA
3190348 0.007 2.01 ⬇ 2.16 1.15 60S acidic ribosomal protein P1 RPLP1
6270307 0.006 2.04 ⬇ 2.04 1.01 40S ribosomal protein S26 (3 sets) RPS26
380575 0.000 2.14 ⬇ 1.49 0.39 Ribosomal protein L23 RPL23
990273 0.012 2.48 ⬇ 3.39 2.08 Ribosomal protein L37a RPL37A
650349 0.008 2.00 ⬇ 2.20 1.19 Ribosomal protein S28 RPS28
Stress and injury related
6100356 0.002 2.84 ⬆ 3.63 5.14 Alkaline phosphatase, liver/bone ALPL
6380672 0.001 2.11 ⬆ 1.42 2.50 Carbonic anhydrase IV CA4
1510681 0.012 2.01 ⬇ 3.56 2.55 Neuroblastoma breakpt family 10 NBPF10
7380706 0.001 2.10 ⬆ 2.61 3.68 Ninjurin 1 NINJ1
1030463 0.004 2.49 ⬆ 3.30 4.62 Prokineticin 2 PROK2
3890326 0.011 2.02 ⬆ 3.43 4.44 Superoxide dismutase 2, mitochon. SOD2
Minimally annotated NCBI
6420563 0.023 2.00 ⬇ 3.85 2.85 LOC100129902 RPS29P11
650735 0.001 2.09 ⬇ 1.86 0.79 LOC100131205 RPL21P28
6650603 0.000 2.66 ⬇ 1.95 0.54 LOC100131905 RPS27P21
7150414 0.003 2.31 ⬇ 2.26 1.06 LOC100132291 RPS27P29
4670634 0.003 2.81 ⬆ 1.69 3.18 LOC100132394 retired
6580017 0.009 2.18 ⬇ 2.81 1.69 LOC100132742 RPL17L
2630347 0.001 2.04 ⬆ 1.17 2.21 LOC100134364 retired
3390674 0.002 2.01 ⬇ 2.11 1.10 LOC391370 RPS12P4
1170551 0.001 2.19 ⬇ 1.55 0.42 LOC646785 RPS10P13
6960373 0.013 2.00 ⬇ 2.23 1.23 LOC644191 RPS26P8
4540241 0.005 2.15 ⬆ 1.10 2.21 C5orf32 CYSTM1
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Prediction of appendicitis from DEG
The PLSD model built on the 37 DEG list, was 100 %
accurate and specific within the discovery set, which is
not surprising given the ability of PLSD models to accur-
ately ‘fit’ data to outcomes. As shown in Fig. 3, the first
3 latent factors in the PLSD model demonstrate tight
clustering of the appendicitis patients (blue) distinct
from patients presenting with other abdominal pain
(red). Clearly, 7 of 9 abdominal patients can be discrimi-
nated by only the first latent factor (t0, X-axis). Two ab-
dominal patients, one with a GI bleed and one with
diverticulitis, are poorly discriminated by the t0 latent
factor shown in the X-axis, but are readily discriminated
by one of the two other factors (Y or Z axis). To deter-
mine whether all 37 transcripts were necessary for
prediction, 16 transcripts with a loading of >0.2 in the
PLSD model were used to rebuild a new PLSD predic-
tion model (Additional file 4: Table S4). This smaller
model, which omitted the defensins, remained quite
strong, predicting 100 % of abdominal cases, 90.9 % of
appendicitis cases, for an overall accuracy of 95 %.
Validation of PLSD prediction model in unrelated samples
To determine the robustness of the prediction model, a
separate group of patients derived from the same overall
cohort were similarly processed for whole blood RNA,
Fig. 2 Hierarchical clustering of 37 differentially expressed genes in appendicitis patients. Transcripts which differed between groups by >2-fold
with a t-test probability of <0.05 (uncorrected) were identified by combined filtering. Following a per-gene normalization, DEGs were subjected
to hierarchical clustering to identify patterns of covariance among the transcripts. The upper block of transcripts from HLA-DRB5 to CA4 are relatively
higher in APP patients (red) compared to patients with other types of abdominal pain (yellow to blue). Conversely, transcripts from defensins (DEFA)
and ribosomal transcripts, were relatively lower in APP than abdominal pain patients
Fig. 3 Partial Least Squares Discriminant (PLSD) Model for
classification of appendicitis from RNA biomarkers. DEGs were
analyzed by PLSD to compose a classification model for appendicitis
based on RNA biomarkers in blood. The 3D plot shows the 20
patients in the discovery set as partitioned by the first 3 of 4 latent
factors in the PLSD model. The red spheres represent abdominal
pain patients (n = 9), and blue shows the cluster of appendicitis
patients (n = 11), as a function of the t0 latent factor (X-axis), the t1
factor (Y-axis), and the t2 factor (Z-axis). The majority of patients (7/9)
are accurately classified by the t0 component alone
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and hybridized independently to Illumina HT 12v4 Bead-
chip arrays. With only minimal normalization to correct
for minor loading and hybridization differences, the PLSD
prediction model was applied to the normalized values for
the 37 transcripts in the model. The PLSD prediction
model correctly identified 8 of 9 true appendicitis patients
(88.9 %) and predicted 3 of 4 patients (75 %) with hernias
as being ‘abdominal pain’. Nearly 90 % sensitivity in an
unrelated cohort quantified on a different microarray run
is encouraging toward the potential robustness of the
model. Notably, the PLSD model includes no clinical vari-
ables, such as fever or white cell count.
Behavior of the RNA biomarkers in non-appendicitis
infections
In 5 patients clinically diagnosed with LRI, which were
not included in PLSD training, the model predicts 4 of 5
as appendicitis (80 %), suggesting that the model may be
sensitive to generalized infectious or inflammatory sig-
nals in blood. Using the 16 DEG model, only 60 % were
diagnosed as appendicitis. As shown in Fig. 4, some
transcripts, such as FCGR3 and NINJ1, were relatively
selectively elevated in APP, but not LRI. Other tran-
scripts, especially defensins, were much more sensitive
to LRI than APP, showing 4–5 fold elevations in LRI
versus HER, and 20-fold elevations in LRI vs APP. Most
transcripts, as demonstrated by CXCR2/IL8Rß, LILRA3,
and ALPL, showed roughly similar changes in LRI and
APP. Of the 37 transcripts, 10 are relatively selective for
APP, 8 are selective for LRI, and 19 behave similarly in
both APP and LRI.
Validation of selected biomarkers using ddPCR in a larger
cohort
To confirm and extend the microarray-based studies, an
additional 29 patients (12 APP, 17 ABD) were recruited
and combined with all available samples from the prior
studies to quantitate the RNA biomarkers using droplet
digital PCR (ddPCR) as an independent method. As
shown in Fig. 5a, the results confirm the microarray
findings that appendicitis patients show significantly ele-
vated circulating levels of mRNA for ALPL and IL8RB,
while showing reduced levels of DEFA1 compared to
patients with other abdominal conditions (ABD). Ab-
dominal patients showed significantly elevated ALPL,
IL8RB, and DEFA1 compared to patients with hernia
(HER). Thus, APP patients are characterized as having
elevated ALPL and IL8RB, without an increase in
DEFA1. In contrast, patients with active lung infections
showed strongly activated DEFA1 mRNA levels with
only small changes in ALPL and IL8RB (Fig. 5b). The
relatively high standard error in the lung group (LRI) is
because 2 of the 5 patients had marginal infections, one
associated with a primary diagnosis of pulmonary
embolism, and the other with a mild respiratory infec-
tion, and both showed small increases in DEFA1 levels.
A separate ongoing study is examining these markers in
pulmonary infections, but the validity of DEFA1 mRNA
is supported by recent microarray studies [25].
Discussion
Currently, there are no approved serum or urine bio-
markers for appendicitis. As noted earlier, abdominal pain
is one of the most common complaints in the ED, and
thus blood biomarkers represent an important unmet
need in clinical medicine. In this discovery and validation
study, we have identified a small set of RNA transcripts
associated with appendicitis. Overall, a prediction model
built on these markers was able to differentiate appendi-
citis from other forms of intra-abdominal pathology, such
as diverticulitis and hernias. Appendicitis is thought to be
an inflammatory disease, similar to diverticulitis or colitis;
however, there was differing activation of certain mRNA
Fig. 4 Behavior of DEG biomarkers in a validation cohort. The 37
DEG biomarker set was applied to transcript expression levels in
patients being treated for either appendicitis (APP, green bars),
lower respiratory infection (LRI, red bars), or hernias (HER, blue bars).
Representative transcripts, such as Fc gamma receptor 3 (FCGR3)
and ninjurin 1 (NINJ1) are shown, in which the transcript behaves
with relatively selective induction in APP, relative to HER or LRI.
Conversely, transcripts in the defensin family (DEFA1, DEFA3), are
significantly elevated in HER patients, relative to APP, but are
strikingly induced in LRI patients. Most transcripts, such as alkaline
phosphatase (ALPL) and the CXCL8 (IL-8) receptors (CXCR2/IL8RB,
CXCR1), were induced in both APP and LRI patients
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biomarkers between these conditions. Furthermore, the
37 DEG markers do not correlate with white blood cell
count, per se, but a careful examination of the transcripts
suggests that the RNA biomarkers may be measuring the
activation state of immune cells, especially neutrophils.
The pattern of transcriptome changes in blood may
help to refine our understanding of the etiology and pro-
gression of acute appendicitis, as shown schematically in
Fig. 6. The classic explanation for appendicitis is that a
fecalith or lymphoid hyperplasia blocks the outflow of
the appendix, resulting in obstruction and ischemia [26].
Outflow obstruction may produce local changes that
favor undesirable changes in the appendix microbiome.
Several recent studies, including next-generation se-
quencing (NGS) of the 16S regions of the microbiome,
have suggested that relatively selective changes in Fuso-
bacteria species are associated with appendicitis [27–30].
Fusobacteria, a type of gram-negative bacteria, can in-
duce toxicity in adjacent host cells, and colitis-like
symptoms in mice, potentially by producing butyric acid
(butyrate) [31].
RT-PCR analysis confirms that inflamed appendix tis-
sue has elevated α-defensin and CXCL8 (IL-8) mRNA
levels [32]. Most studies have observed higher circulat-
ing CXCL8 levels in patients with appendicitis [33–35],
and the inflamed appendix is known to locally express
elevated CXCL8 [36]. Likewise, Fusobacterium nucleatum
biofilms stimulate CXCL8 production in human oral epi-
thelium cell lines [37] and Fusobacterium necrophorum
induces CXCL8 production in cultured mesothelial cells
[38]. Neutrophils attracted to sites of mucosal inflamma-
tion are a major component of the normal maintenance of
barrier functions, and they are responsive to a variety of
soluble signals within the intestinal microenvironment, in-
cluding hypoxia [39].
Thus, the absence of elevated α-defensin transcripts in
the presence of elevated levels of mRNA for both
CXCL8/IL-8 receptors suggests that circulating immune
cells are primed by CXCL8, LPS, butyrate, and local hyp-
oxia known to be produced in the inflamed appendix.
However, it is possible that the immune cells are not dir-
ectly contacting the bacterial infection, which would ele-
vate defensins, as demonstrated clearly in the LRI
patients. The increased mRNA levels for ALPL, which is
a secondary granule constituent, as opposed to defensins
and MPO, which are azurophilic granule components, is
consistent with the pre-existing view that secondary
Fig. 5 ddRT-PCR validation of selected mRNA biomarkers in an
expanded cohort. Patient samples from the discovery and validation
sets were expanded to include an additional set of appendicitis and
abdominal pain patients drawn from the same cohort. Panel a ALPL,
DEFA, IL8RB mRNA was quantitated by ddRT-PCR and then expressed as
percent of the ACTB value from each subject. Mean and SEM are shown
for patients with non-appendicitis abdominal pain (ABDOM, n= 30) versus
confirmed appendicitis (APPENDIX, n= 30). Panel b The same biomarkers
are shown for ABDOM (n= 30) versus suspected lung infections (LUNG,
n= 5). In both panels, * indicates p< 0.05, **indicates p< 0.005
Fig. 6 Model of appendicitis biomarker pathophysiology. It is
believed that compacted fecal bodies, termed fecaliths, may occlude
the outflow tract of the appendix, causing inflammatory conditions
that are conducive to infection in the appendix. Microbiome analysis
of inflamed appendices typically indicates a predominance of
biofilm-forming bacteria, such as Fusobacteria. The biofilm protects the
bacteria from antibiotics, and from direct immune attack, but soluble
factors produced by the bacteria, such as LPS (endotoxins) and butyrate,
or cellular factors such as hypoxia and CXCL8, can diffuse into adjacent
lymphatic and circulatory beds to activate neutrophils. The primed
neutrophils respond with elevated transcript levels of alkaline phosphatase
(ALPL), interleukin-8 receptor beta (CXCR2/IL8Rß) and related biomarkers
of local infection. Background images of appendix and neutrophil courtesy
of Blausen.com staff, Wikiversity Journal of Medicine
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granules respond to particulate and soluble neutrophil
stimulators, while the azurophilic granule is principally
responsive only to phagocytizable particles [40].
In addition to the CXCL8 receptors, several other tran-
scripts appear to be plausible biomarkers of localized in-
flammation. Notably, ALPL, along with IL8RB/CXCR2,
was identified as an expression biomarker of asthma in-
flammatory subtypes [41]. In addition to these interesting
innate immune markers, the results revealed unexpected
changes in the ribosomal system. Humans utilize 4 riboso-
mal RNAs, which are non-coding (5S, 5.8S, 18S, 28S), and
~80 ribosomal proteins to build multimeric translation
complexes. Additionally, there are ~2000 ribosomal
protein pseudogenes, which are thought to derive from
inactivated duplications, but may be processed to varying
degrees, and could have regulatory functions [42]. Tran-
scripts for 18S and 28S, both originating from multiple
45S genes, were increased in the appendicitis blood RNA,
which could be due to both increased transcription from
active rDNA genes [43], as well engagement of previously
inactive rDNA transcription units [23]. Conversely, most
of the coding transcripts, such as RPLP1 and RPS26, were
decreased in the blood of appendicitis patients. Because
the specific pattern of ribosomal proteins defines the type
of RNAs that are engaged and translated [44], it is possible
that the translational machinery is being re-geared to react
to pathogens. Unexpectedly, most of the poorly annotated
transcripts were mapped to ribosomal protein pseudo-
genes, suggesting that either the probesets are incorrectly
detecting a change in coding ribosomal protein tran-
scripts, or the pseudogenes are somehow regulated in
conjunction with the reconfigured translational machin-
ery. Nonetheless, the ribosomal transcript changes reflect
a small fraction of the ribosomal machinery, not a sweep-
ing change in ‘housekeeping’ genes. Conceptually, the pat-
tern of chemokine, defensin, stress-related, and ribosomal
processing changes is consistent with the immune system
being ‘primed’ as the immune cells pass through an in-
flammatory field created by a localized biofilm infection.
Other transcripts were readily associated with tissue
injury or inflammation, but not previously associated
with pathogen infection (Table 2). For instance, NINJ1
was identified as a transcript strongly upregulated after
peripheral nerve injury [45]. PROK2 is elevated in colitis
tissue [46], which, like appendicitis, is an inflammatory
condition in the GI tract. Likewise, ALPL has a well-
known role in modulating diverse inflammatory condi-
tions not limited to infectious disease [47]. Consistent
with the current data, human neutrophils treated ex vivo
with TNF-α and/or GM-CSF also show induction of
transcripts for CXCR1, CXCR2/IL8RB, FCGR3B, NINJ1,
and PROK2 [48].
Other investigators have sought to develop protein bio-
markers for appendicitis in the blood, such as bilirubin
[49], C-reactive protein (CRP) [50], and pro-calcitonin
(PCT) [51]. However, recent comparisons of these bio-
markers had difficulty improving on a purely clinical pre-
diction model, such as the Alvarado score (ROC= 0.74, vs
CRP = 0.61, PCT = 0.69) [52]. Recently, a combination of
WBC, CRP, and MRP8/14 (S100A8/S100A9) was shown to
be 96 % sensitive, but 43 % specific for acute appendicitis
[50]. Likewise, a multivariate model built on plasma protein
levels of serum amyloid (SAA), myeloperoxidase (MPO),
and MMP9 was less diagnostic than a largely clinical model
(ROC= 0.71 vs 0.91 clinical model) [53].
While RNA-based diagnostic tests are currently on the
market for breast cancer progression (MammaPrint, Onco-
Type Dx), transplant rejection (AlloMap), and coronary ar-
tery disease (CorusCAD), to our knowledge, this is the first
report to assess blood RNA as a potential biomarker of ap-
pendicitis. Among the strengths of the present approach is
that the test and validation sets included controls for surgi-
cal, inflammatory, and infectious factors. Further, the RNA
profiling was broad and largely unbiased, and detected the
same key pathways in the test and validation study. Third,
unlike protein biomarkers, which can be difficult to meas-
ure due to interference by other high-abundance proteins,
mRNA is highly reproducible, very sensitive to perturb-
ation, and can be localized to specific cell types (e.g. neutro-
phils) for disease monitoring.
In addition to these strengths, the present study has
certain limitations. First, the sizes of the cohorts used in
the discovery phase were modest. As a consequence, the
range of intra-abdominal diseases that we were able to
assess was limited. The LRI biomarkers must be assessed
cautiously due to the small and heterogeneous group.
Second, due to randomness in enrollment, the ethnicity
was unbalanced between groups, and this may have in-
troduced a bias into the interpretation. However, analysis
of the ddPCR data by race and gender did not identify
differences (not shown). Nonetheless, we have success-
fully utilized a genome-wide RNA transcript profiling to
identity potential genomic biomarkers of appendicitis.
Overall, the detected biomarkers are consistent with
prior published evidence that bacterial biofilms in the
appendix may be an important putative pathophysio-
logical mechanism in appendicitis that can be detected
by the RNA profile of circulating neutrophils.
Conclusions
 Transcript profiling of blood identified RNA
biomarkers in patients with confirmed appendicitis.
 Secondary granule markers, such as ALPL were
increased, while azurophilic granule markers, such
as DEFA1, decreased in appendicitis.
 Lung infections increased azurophilic markers more
than secondary granule markers.
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 Transcript changes associated with acute
appendicitis are consistent with immune priming by
a bacterial biofilm, probably transmitted by soluble
factors such CXCL8, LPS, and local hypoxic
conditions that activate neutrophils transiting the
inflamed area.
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